117 related articles for article (PubMed ID: 38182134)
1. Integrating Frailty Assessment to Enhance Care in Cancer Patients with Borderline Eastern Cooperative Oncology Group Performance Status.
Hsu CC; Hung YS; Yu SM; Hsueh SW; Chou WC
Am J Hosp Palliat Care; 2024 Jan; ():10499091231226062. PubMed ID: 38182134
[TBL] [Abstract][Full Text] [Related]
2. External validation and diagnostic value of the Elderly Functional Index version 2.0 for assessing functional status and frailty in older Danish patients with gastrointestinal cancer receiving chemotherapy: A prospective, clinical study.
Jespersen E; Soo WK; Minet LR; Eshoj HR; King MT; Pfeiffer P; Möller S
J Geriatr Oncol; 2024 Jan; 15(1):101675. PubMed ID: 38070322
[TBL] [Abstract][Full Text] [Related]
3. Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer.
Neeman E; Gresham G; Ovasapians N; Hendifar A; Tuli R; Figlin R; Shinde A
Oncologist; 2019 Dec; 24(12):e1460-e1466. PubMed ID: 31227648
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Frailty and Risk of Chemotherapy Toxicity at a Geriatric-Oncology Multidisciplinary Clinic.
Raza S; Rudolph JL; Mujahid N; Neupane I; Monteiro JFG; Singh M; Khurshid H
R I Med J (2013); 2023 May; 106(4):13-18. PubMed ID: 37098141
[TBL] [Abstract][Full Text] [Related]
5. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.
Sehgal K; Gill RR; Widick P; Bindal P; McDonald DC; Shea M; Rangachari D; Costa DB
JAMA Netw Open; 2021 Feb; 4(2):e2037120. PubMed ID: 33570575
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy - The randomized NORDIC9-study.
Liposits G; Ryg J; Skuladottir H; Winther SB; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Glimelius B; Sorbye H; Pfeiffer P
J Geriatr Oncol; 2023 Jan; 14(1):101408. PubMed ID: 36494261
[TBL] [Abstract][Full Text] [Related]
7. Impact of palliative chemotherapy and best supportive care on overall survival and length of hospitalization in patients with incurable Cancer: a 4-year single institution experience in Japan.
Murakawa Y; Sakayori M; Otsuka K
BMC Palliat Care; 2019 Jun; 18(1):45. PubMed ID: 31159782
[TBL] [Abstract][Full Text] [Related]
8. Functional status in older patients with cancer and a frailty risk profile: A multicenter observational study.
Meert G; Kenis C; Milisen K; Debruyne PR; De Groof I; Focan C; Cornélis F; Verschaeve V; Bachmann C; Bron D; Den Bulck HV; Schrijvers D; Langenaeken C; Specenier P; Jerusalem G; Praet JP; Lobelle JP; Flamaing J; Wildiers H; Decoster L
J Geriatr Oncol; 2022 Nov; 13(8):1162-1171. PubMed ID: 36085275
[TBL] [Abstract][Full Text] [Related]
9. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
[TBL] [Abstract][Full Text] [Related]
10. Worse ECOG-PS Is Associated with Increased 30-Day Mortality among Adults Older than 90 Years Undergoing Non-Cardiac Surgery: A Single-Center Retrospective Study.
Iwasaki M; Ishikawa M; Namizato D; Sakamoto A
J Nippon Med Sch; 2022 Jun; 89(3):295-300. PubMed ID: 34840213
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and co-incidence of geriatric syndromes according to the ECOG performance status in older cancer patients.
Topcu A; Yasin AI; Besiroglu M; Sucuoglu Isleyen Z; Alaca Topcu Z; Simsek M; Turk HM; Seker M; Soysal P
Front Med (Lausanne); 2024; 11():1331246. PubMed ID: 38439897
[TBL] [Abstract][Full Text] [Related]
12. Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review and Meta-analysis.
Yang F; Markovic SN; Molina JR; Halfdanarson TR; Pagliaro LC; Chintakuntlawar AV; Li R; Wei J; Wang L; Liu B; Nowakowski GS; Wang ML; Wang Y
JAMA Netw Open; 2020 Aug; 3(8):e2012534. PubMed ID: 32766800
[TBL] [Abstract][Full Text] [Related]
13. Chemoimmunotherapy in patients with extensive-stage small cell lung cancer and a poor performance status.
Agarwal M; Liu A; Almquist D; Langlais BT; Leventakos K; Yu NY; Manochakian R; Ernani V
Cancer; 2023 Nov; 129(22):3546-3553. PubMed ID: 37548029
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of Eastern Cooperative Oncology Group performance status on overall survival among patients with metastatic prostate cancer: a systematic review and meta-analysis.
Assayag J; Kim C; Chu H; Webster J
Front Oncol; 2023; 13():1194718. PubMed ID: 38162494
[TBL] [Abstract][Full Text] [Related]
15. Influence of interdisciplinary frailty screening on perioperative complication rates in elderly ovarian cancer patients: results of a retrospective observational study.
Anic K; Varchola J; Schmidt MW; Schwab R; Linz VC; Schmidt M; Hardt R; Hartmann EK; Ruckes C; Hasenburg A; Battista MJ
Arch Gynecol Obstet; 2023 Jun; 307(6):1929-1940. PubMed ID: 36434440
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer.
Abbass T; Dolan RD; MacLeod N; Horgan PG; Laird BJ; McMillan DC
Clin Nutr ESPEN; 2020 Dec; 40():349-356. PubMed ID: 33183562
[TBL] [Abstract][Full Text] [Related]
17. Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3.
Agarwal M; Liu A; Langlais BT; Leventakos K; Yu NY; Almquist D; Manochakian R; Ernani V
Clin Lung Cancer; 2023 Nov; 24(7):591-597. PubMed ID: 37365076
[TBL] [Abstract][Full Text] [Related]
18. Outcomes with abiraterone acetate in metastatic castration-resistant prostate cancer patients who have poor performance status.
Azad AA; Eigl BJ; Leibowitz-Amit R; Lester R; Kollmannsberger C; Murray N; Clayton R; Heng DY; Joshua AM; Chi KN
Eur Urol; 2015 Mar; 67(3):441-7. PubMed ID: 24508071
[TBL] [Abstract][Full Text] [Related]
19. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
[TBL] [Abstract][Full Text] [Related]
20. Use of the Rockwood Clinical Frailty Scale in patients with advanced hepatopancreaticobiliary malignancies.
Shah D; Kapacee ZA; Lamarca A; Hubner RA; Valle JW; McNamara MG
Expert Rev Anticancer Ther; 2022 Sep; 22(9):1009-1015. PubMed ID: 35768183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
